Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.

Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R, Goudsmit J, Havenga MJ, Kostense S.

J Clin Microbiol. 2003 Nov;41(11):5046-52.

2.

Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.

Harvey BG, Hackett NR, El-Sawy T, Rosengart TK, Hirschowitz EA, Lieberman MD, Lesser ML, Crystal RG.

J Virol. 1999 Aug;73(8):6729-42.

3.

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines.

Aste-Amézaga M, Bett AJ, Wang F, Casimiro DR, Antonello JM, Patel DK, Dell EC, Franlin LL, Dougherty NM, Bennett PS, Perry HC, Davies ME, Shiver JW, Keller PM, Yeager MD.

Hum Gene Ther. 2004 Mar;15(3):293-304.

PMID:
15018738
4.

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.

Roberts DM, Nanda A, Havenga MJ, Abbink P, Lynch DM, Ewald BA, Liu J, Thorner AR, Swanson PE, Gorgone DA, Lifton MA, Lemckert AA, Holterman L, Chen B, Dilraj A, Carville A, Mansfield KG, Goudsmit J, Barouch DH.

Nature. 2006 May 11;441(7090):239-43. Epub 2006 Apr 16.

PMID:
16625206
5.

Repeated administration of adenovector in the eye results in efficient gene delivery.

Hamilton MM, Brough DE, McVey D, Bruder JT, King CR, Wei LL.

Invest Ophthalmol Vis Sci. 2006 Jan;47(1):299-305.

PMID:
16384977
6.

[Anti-adenovirus neutralizing antibodies and Gag-specific cellular immune responses in Macaca fascicularis immunized with Ad5-HIVgag].

Li Y, Yang L, Yang L, Chen DY, Feng X, Yu SQ, Li ZL, Zeng Y.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Dec;25(6):413-5. Chinese.

PMID:
22734222
7.

Development of adenovirus serotype 35 as a gene transfer vector.

Seshidhar Reddy P, Ganesh S, Limbach MP, Brann T, Pinkstaff A, Kaloss M, Kaleko M, Connelly S.

Virology. 2003 Jul 5;311(2):384-93.

8.
9.
10.

Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery.

Wang M, Hemminki A, Siegal GP, Barnes MN, Dmitriev I, Krasnykh V, Liu B, Curiel DT, Alvarez RD.

Gynecol Oncol. 2005 Feb;96(2):341-8.

PMID:
15661219
11.

Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.

Sumida SM, Truitt DM, Kishko MG, Arthur JC, Jackson SS, Gorgone DA, Lifton MA, Koudstaal W, Pau MG, Kostense S, Havenga MJ, Goudsmit J, Letvin NL, Barouch DH.

J Virol. 2004 Mar;78(6):2666-73.

13.

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

Barouch DH, Pau MG, Custers JH, Koudstaal W, Kostense S, Havenga MJ, Truitt DM, Sumida SM, Kishko MG, Arthur JC, Korioth-Schmitz B, Newberg MH, Gorgone DA, Lifton MA, Panicali DL, Nabel GJ, Letvin NL, Goudsmit J.

J Immunol. 2004 May 15;172(10):6290-7.

14.

Comparison of two high-throughput assays for quantification of adenovirus type 5 neutralizing antibodies in a population of donors in China.

Liu Q, Nie J, Huang W, Meng S, Yuan B, Gao D, Xu X, Wang Y.

PLoS One. 2012;7(5):e37532. doi: 10.1371/journal.pone.0037532. Epub 2012 May 24.

15.

Adenovirus vectors composed of subgroup B adenoviruses.

Sakurai F, Kawabata K, Mizuguchi H.

Curr Gene Ther. 2007 Aug;7(4):229-38. Review.

PMID:
17969556
16.

Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity.

Thorner AR, Lemckert AA, Goudsmit J, Lynch DM, Ewald BA, Denholtz M, Havenga MJ, Barouch DH.

J Virol. 2006 Dec;80(24):12009-16. Epub 2006 Oct 11.

17.

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum.

Jin J, Ma H, Xu L, An D, Sun S, Huang X, Kong W, Jiang C.

J Virol Methods. 2013 Feb;187(2):362-7. doi: 10.1016/j.jviromet.2012.11.014. Epub 2012 Nov 20.

PMID:
23178532
18.

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

Gahéry-Ségard H, Farace F, Godfrin D, Gaston J, Lengagne R, Tursz T, Boulanger P, Guillet JG.

J Virol. 1998 Mar;72(3):2388-97.

19.
20.

Comparison of adenoviruses from species B, C, E, and F after intravenous delivery.

Stone D, Liu Y, Li ZY, Tuve S, Strauss R, Lieber A.

Mol Ther. 2007 Dec;15(12):2146-53. Epub 2007 Sep 25.

PMID:
17895860
Items per page

Supplemental Content

Write to the Help Desk